What does LouksPharma do?

LouksPharma is a pharmacy in Fernelmont. Private Limited, started on 18 July 2023, 1 establishment.

What is the address of LouksPharma?

The registered office of LouksPharma is located at Rue de la Chasse, March. 81, 5380 Fernelmont.

Is LouksPharma still active?

Yes. According to the CBE (29 October 2026) LouksPharma is active, legal situation “Normale toestand”, started on 18 July 2023.

Is LouksPharma registered on Peppol?

Yes, LouksPharma is registered on the Peppol network with ID 0208:0804096940.

What is the enterprise number of LouksPharma?

The enterprise number of LouksPharma is BE0804096940.

When was LouksPharma founded?

LouksPharma was founded on 18 July 2023.

Is LouksPharma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 July 2023; 2 annual accounts filed, latest fiscal year 2025.

How much profit did LouksPharma make in 2025?

LouksPharma posted a profit after taxes of € 12,820 in financial year 2025.

What is the revenue of LouksPharma?

As a small company, LouksPharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 28,810.

LouksPharma (Private Limited) - Fernelmont - BE0804096940

Dossier LouksPharma, printed on 29 October 2026 from databakkes.be/en/0804096940/loukspharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LouksPharma from Fernelmont, company number BE0804096940, closed financial year 2025 with a result of € 12,820 after tax. For that financial year LouksPharma recorded a gross margin of € 28,810 and equity of € 27,471. Compared with financial year 2024, the result moved from € 12,151 to € 12,820. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 13, 2026.

What it is worth Growing

€ 27,471

▲ 88% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 12,820

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 20,101

▲ 89% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 24,971.

People and assets in 2025

Vehicles and equipment

€ 36,093

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 28,646

▼ 30% vs 2024

€ 12,896 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 3,455

▼ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,798

▼ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 28,478 Gross margin 2024: € 28,478 First fiscal year in the series	€ 28,810 Gross margin 2025: € 28,810 ▲ 1% vs 2024 (€ 28,478) Favourable step	▲ 1%
Profit after taxes	€ 12,151 Profit after taxes 2024: € 12,151 First fiscal year in the series	€ 12,820 Profit after taxes 2025: € 12,820 ▲ 6% vs 2024 (€ 12,151) Favourable step	▲ 6%
Equity	€ 14,651 Equity 2024: € 14,651 First fiscal year in the series	€ 27,471 Equity 2025: € 27,471 ▲ 88% vs 2024 (€ 14,651) Favourable step	▲ 88%
Total debts	€ 58,347 Total debts 2024: € 58,347 First fiscal year in the series	€ 45,183 Total debts 2025: € 45,183 ▼ 23% vs 2024 (€ 58,347) Favourable step	▼ 23%
Cash	€ 10,615 Cash 2024: € 10,615 First fiscal year in the series	€ 20,101 Cash 2025: € 20,101 ▲ 89% vs 2024 (€ 10,615) Favourable step	▲ 89%
Retained profit	€ 12,151 Retained profit 2024: € 12,151 First fiscal year in the series	€ 24,971 Retained profit 2025: € 24,971 ▲ 106% vs 2024 (€ 12,151) Favourable step	▲ 106%
Bank debt	€ 41,009 Bank debt 2024: € 41,009 First fiscal year in the series	€ 28,646 Bank debt 2025: € 28,646 ▼ 30% vs 2024 (€ 41,009) Favourable step	▼ 30%
Balance sheet total	€ 72,998 Balance sheet total 2024: € 72,998 First fiscal year in the series	€ 72,655 Balance sheet total 2025: € 72,655 Unchanged (€ 72,998) Unchanged

Key figures of LouksPharma, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to LouksPharma?

What happened at LouksPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 13, 2026 New annual accounts for financial year 2025: profit of € 12,820 (▲ 6% vs 2024). Source: NBB ↗
Jul 18, 2023 New establishment in Fernelmont. KBO
Jul 18, 2023 Start of the company according to the CBE. KBO

In short

From € 12,151 profit in 2024 to € 12,820 profit in 2025.

Paid € 6,416 in corporate taxes since 2024.

Best year ever: 2025, with € 12,820 profit.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Chasse, March. 81

5380 Fernelmont

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

BURO81

€ 29,481 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0804.096.940
VAT number: BE 0804.096.940
Registered office: Rue de la Chasse, March. 81, 5380 Fernelmont
Names & denominations: LouksPharma
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 July 2023
Peppol: Active · Active since 1 Jan 2026
Contact: [email protected] +32471927187
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

LouksPharma